Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02286401 · ClinicalTrials.gov registry record
Functional Assessment of Coronary Artery Disease by CTA Flow Encoding
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 19
- Enrollment target
NCT02286401: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02286401 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02286401 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this pilot study proposal is to test the ability of Transluminal Flow Encoding (TAFE) to evaluate vessel specific ischemia in patients with a clinical indication for invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurements for suspected coronary disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02286401
The ClinicalTrials.gov registry entry for NCT02286401 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02286401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02286401 about?
NCT02286401 is a clinical study titled "Functional Assessment of Coronary Artery Disease by CTA Flow Encoding". The purpose of this pilot study proposal is to test the ability of Transluminal Flow Encoding (TAFE) to evaluate vessel specific ischemia in patients with a clinical indication for invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurements for suspected coronary disease.
What is the current status of trial NCT02286401?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2014-10. Estimated completion is 2016-12-31.
Who is sponsoring clinical trial NCT02286401?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.